NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

So, I don't get it many here were complaining that the 2018 interim was not published in a first rate journal but now you're saying it couldn't have been?


'Interim REVERSE-IT trial results published in NEJM Evidence'

>>We are pleased to see the publication of these highly positive interim Phase 3 results in a leading peer-reviewed scientific publication like NEJM Evidence,” said John Lee chief medical officer of PhaseBio.

https://cardiovascularnews.com/interim-reverse-it-trial-results-published/


I've already posted Powers comments suggesting that the Interim was unblinded.

And, since the Transitional Medicine Journal could have shaved off time having already published the interim data, they wasted a good year so far waiting for another alleged journal review.

Annual Journal Metrics

Speed
60 days to first decision for reviewed manuscripts only
31 days to first decision for all manuscripts
115 days from submission to acceptance
13 days from acceptance to publication